A detailed history of Smartleaf Asset Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 448 shares of ALKS stock, worth $13,104. This represents 0.0% of its overall portfolio holdings.

Number of Shares
448
Previous 268 67.16%
Holding current value
$13,104
Previous $6.51 Million 89.48%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.01 - $28.55 $4,141 - $5,139
180 Added 67.16%
448 $12.3 Million
Q2 2024

Aug 13, 2024

BUY
$23.21 - $27.24 $6,220 - $7,300
268 New
268 $6.51 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.8B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.